Creative Medical Technology Holdings, Inc. (CELZ) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Phoenix, AZ, United States. The current CEO is Timothy Warbington.
CELZ has IPO date of 2015-11-06, 4 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $5.91M.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
